Skip to content

Study of an ayurvedic therapy Matra basti with Shatpaka Bala Taila in the management of abnormal uterine bleeding

Evaluation of Shatpaka Bala Taila Matra Basti in the management of Asrigdar - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/106957
Enrollment
30
Registered
2026-03-27
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N939- Abnormal uterine and vaginal bleeding, unspecified

Interventions

None listed

Sponsors

Dhritismita Sarma
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Reproductive age group Patients having clinical features of Asrigdar

Exclusion criteria

Exclusion criteria: Pregnancy positive patients Coagulation disorders Hemoglobin less than 8g/dl Patients with any malignancy Patients with major surgical or medical disorders like Diabetes mellitus, asthma, kidney disease, liver disease

Design outcomes

Primary

MeasureTime frame
Reduction in amount of menstrual blood lossTimepoint: After 4weeks

Secondary

MeasureTime frame
To normalise the menstrual cycle interval & duration & reduction of symptoms like pain generalized weaknessTimepoint: After 12 weeks

Countries

India

Contacts

Public ContactDr Kaushalya Khakhlary

Government Ayurvedic College and Hospital Jalukbari Guwahati Assam 781014

drkaushalya01@gmail.com8638787369

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026